N(epsilon)- (3- formyl- 3,4- dihydropiperidino)lysine

structure in first source

Also Known As:

FDP-Lys

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Diabetic Retinopathy (Retinopathy, Diabetic) 01/01/2017 - "To determine the presence of Nε-(3-formyl-3,4-dehydropiperidino) lysine adduct (FDP-Lys), unsaturated aldehyde acrolein-derived lipoxidation end-product, in fibrovascular tissues obtained from patients with proliferative diabetic retinopathy (PDR). "